Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus [1]

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 6, 2006, Pages 1307-

  Hmouda, Houssem ^a   Ben Salem, Chaker ^b   Bouraoui, Kamel ^b   Jemni, Letaief ^c  

^a SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^b UNIVERSITY OF SOUSSE   (Tunisia)

^c Clinique des Oliviers   (Tunisia)

Author keywords

Antibiotics; Microbial infections; MRSA; Trimethoprim sulfamethoxazole

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTHRITIS; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTERVERTEBRAL DISK DEGENERATION; KIDNEY ABSCESS; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OSTEITIS; PROSTHESIS INFECTION; PSOAS ABSCESS; RISK ASSESSMENT; RISK FACTOR; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL VIABILITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33845358488     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl417     Document Type: Letter

References (5)

1. Kaka AS, Rueda AM, Shelburne SA III et al. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2006; 58: 680-3.
2. Jemni L, Hmouda H, Letaief A. Efficacy of trimethoprim/sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus: A report from Tunisia. Clin Infect Dis 1994; 19: 202-3.
3. Adra M, Lawrence KR. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother 2004; 38: 338-41.
4. Weber SG, Gold HS, Hooper DC et al. Fluoroquinolones and the risk of methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003; 9: 1415-22.
5. Bisognano C, Vaudaux P, Rohner P et al. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1428-37.